Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
Processa Pharmaceuticals, a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for cancer patients, announced that it has secured a strategic investment and that it is evaluating corporate cryptocurrency treasury strategies as part of its broader financial and growth objectives. We believe that strategic engagement with emerging financial technologies,......